Literature DB >> 21121840

Inhibition of mutated BRAF in melanoma.

Taegyun Kim, Jihyun Kim, Min-Geol Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121840     DOI: 10.1056/NEJMc1010755

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

Review 2.  Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

Authors:  Michael Fay; Richard Head; Jennifer Martin
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

Review 3.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

4.  Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis.

Authors:  Ruifeng Guo; Xianfu Wang; Jie Chen; Ellizabeth Gillies; Kar-Ming Fung; Shibo Li; Lewis A Hassell
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: implications for combination therapy for melanoma brain metastases.

Authors:  Shruthi Vaidhyanathan; Rajendar K Mittapalli; Jann N Sarkaria; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2014-05-29       Impact factor: 3.922

Review 6.  Bridging scales in cancer progression: mapping genotype to phenotype using neural networks.

Authors:  Philip Gerlee; Eunjung Kim; Alexander R A Anderson
Journal:  Semin Cancer Biol       Date:  2014-05-12       Impact factor: 15.707

7.  A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.

Authors:  Celeste Lebbe; Mickael Guedj; Nicole Basset-Seguin; Marie Pierre Podgorniak; Suzanne Menashi; Anne Janin; Samia Mourah
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

8.  Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies.

Authors:  Michael Zeisberg; Elisabeth M Zeisberg
Journal:  Fibrogenesis Tissue Repair       Date:  2015-09-01

Review 9.  VISTA, PDL-L1, and BRAF-A Review of New and Old Markers in the Prognosis of Melanoma.

Authors:  Andreea Cătălina Tinca; Iuliu Gabriel Cocuz; Mihaela Cornelia Șincu; Raluca Niculescu; Adrian Horațiu Sabău; Diana Maria Chiorean; Andreea Raluca Szőke; Ovidiu Simion Cotoi
Journal:  Medicina (Kaunas)       Date:  2022-01-04       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.